The Searle Company Limited

SEARL

PK0061701014

Pharmaceuticals

End-of-day quote Pakistan S.E. Other stock markets 23:00:00 21/05/2024 BST			5-day change	1st Jan Change
57.18 ^PKR	-3.18%		-3.72%	+11.07%

2023	Euro zone sovereign bond yields approach 8-month low ahead of US data	RE
2023	The Searle Company Limited Announces Board Changes	CI

The Searle Company Limited Appoints Arshad Anis as Director

June 08, 2016 at 10:18 am

The Searle Company Limited announced that Mr. Arshad Anis has been appointed as Director with effect from May 16, 2016 in place of Ms. Faiza Naeem.

Latest news about The Searle Company Limited

Euro zone sovereign bond yields approach 8-month low ahead of US data	12-12	RE
The Searle Company Limited Announces Board Changes	11-01	CI
The Searle Company Limited Reports Earnings Results for the Full Year Ended June 30, 2023	27/09/23	CI
Euro zone yields edge lower after Fed remarks, ahead of ECB	27/07/23	RE
Norman Broadbent returns to pre-pandemic levels with revenue boost	31/05/23	AN
The Searle Company Limited agreed to acquire Searle IV Solutions Pvt Ltd and Stellar Ventures Private Limited for INR 7.3 billion.	24/05/23	CI
Indonesia Emerges as Second Largest Cobalt Producer -- Commodities Roundup	10/05/23	DJ
The Searle Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	27/04/23	CI
The Searle Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	02/03/23	CI
UK Gilt Remit Expected to Decline to GBP246 Billion in FY2023-24	22/02/23	DJ
The Searle Company Limited has filed an IPO in the amount of PKR 4.544734 billion.	15/12/22	CI
British crime agency recovers $65 million of suspect money in Barclays accounts	25/11/22	RE
UK bond dealers see jump in gilt issuance for 2023/24- Reuters poll	16/11/22	RE
Conservative activist steers U.S. Supreme Court college race cases	27/10/22	RE
The Searle Company Limited Reports Earnings Results for the First Quarter Ended September 30, 2022	26/10/22	CI
Outlook for Gilts Remains Bearish, Says Citi	07/10/22	DJ
The Searle Company Limited Reports Earnings Results for the Full Year Ended June 30, 2022	03/10/22	CI
Analysis-UK bonds and pound at centre of storm as tax shock hammers confidence	23/09/22	RE
The Searle Company Limited(KASE:SEARL) dropped from S&P Global BMI Index	19/09/22	CI
Tesla Legal Chief David Searle Who Led Purchasing Probe Has Left Automaker - Bloomberg News	17/08/22	RE
TESLA LEGAL CHIEF DAVID SEARLE WHO LED PURCHASING PROBE HAS LEFT…	17/08/22	RE
Unilever ups sales guidance after price hikes help it beat forecast	26/07/22	RE
Tesla Executive Facing Scrutiny in Internal Investigation, Bloomberg Says	21/07/22	DJ
The Searle Company Limited acquired OBS Pakistan Limited.	21/05/22	CI
The Searle Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	07/05/22	CI

Chart The Searle Company Limited

Duration

Period

More charts

The Searle Company Limited is a Pakistan-based company, which is engaged in the manufacture of pharmaceuticals and other consumer products. The Companyâs product categories include pharmaceutical, biopharmaceutical, nutraceutical, nutrition, consumer, and medical devices and disposables. The Company's product portfolio in the pharmaceutical range includes therapeutic areas, such as cardiovascular, respiratory care, gastroenterology, pain management, central nervous system (CNS), ortho care, neuropsychiatry, probiotics, antibiotics, and nutritional care. Its pharmaceutical products include Analgesic & Muscle-Relaxant, Anti-Allergy & Anti-Tussive, Anti-Anemic, Anti-Chelating, Anti-infective, Anti-Neoplastic, Anti-Thrombotic, Cardiovascular, Endocrinology & Metabolism. It also focuses on specialty generic branded portfolios and targeting differentiated products. Its subsidiaries include IBL HealthCare Limited, Searle Pharmaceuticals (Private) Limited, and others.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

57.18 PKR

Average target price

65 PKR

Spread / Average Target

+13.68%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
THE SEARLE COMPANY LIMITED	+11.07%	80.16M
ELI LILLY AND COMPANY	+37.74%	723B
NOVO NORDISK A/S	+34.11%	595B
JOHNSON & JOHNSON	-2.07%	369B
MERCK & CO., INC.	+20.25%	332B
ABBVIE INC.	+2.99%	282B
ASTRAZENECA PLC	+17.02%	244B
NOVARTIS AG	+9.80%	208B
ROCHE HOLDING AG	-4.46%	205B
PFIZER, INC.	+2.81%	168B

Other Pharmaceuticals